RESULTS FROM A PHASE I/II CLINICAL TRIAL ON ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR GENE THERAPY IN PATIENTS WITH EXUDATIVE AGE-RELATED MACULAR DEGENERATION

被引:0
|
作者
Lai, Chooi-May [1 ]
Magno, Aaron [2 ]
Pierce, Cora [2 ]
Samulski, Richard J. [3 ,4 ]
Chalberg, Thomas W. [5 ]
Blumenkranz, Mark S. [6 ]
Constable, Ian J. [1 ]
Rakoczy, Elizabeth P. [1 ]
机构
[1] Univ Western Australia, Ctr Ophthalmol & Visual Sci, Crawley, WA, Australia
[2] Lions Eye Inst, Nedlands, WA, Australia
[3] Univ N Carolina, Dept Pharmacol, Chapel Hill, NC USA
[4] Univ N Carolina, Gene Therapy Ctr, Chapel Hill, NC USA
[5] Avalanche Biotechnol, San Francisco, CA USA
[6] Byers Eye Inst Stanford, Palo Alto, CA USA
来源
JOURNAL OF GENE MEDICINE | 2013年 / 15卷 / 8-9期
关键词
D O I
暂无
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
引用
收藏
页码:319 / 319
页数:1
相关论文
共 50 条
  • [21] Submacular Hemorrhage Rates Following Anti-Vascular Endothelial Growth Factor Injections for Exudative Age-Related Macular Degeneration
    Kaufmann, Gabriel t.
    Boucher, Nicholas
    Sharma, Chakshu
    Aggarwal, Nitika
    Starr, Matthew r.
    AMERICAN JOURNAL OF OPHTHALMOLOGY, 2025, 270 : 172 - 182
  • [22] Progression of macular atrophy in patients undergoing anti-vascular endothelial growth factor therapy for neovascular age-related macular degeneration
    Cho, Han Joo
    Park, Sang Min
    Kim, Jaemin
    Nah, Seung Kwan
    Lee, Jihyun
    Lee, Dong Won
    Kim, Jong Woo
    ACTA OPHTHALMOLOGICA, 2021, 99 (04) : E540 - E546
  • [24] Examining the causes of dropout of anti-vascular endothelial growth factor therapy for age-related macular degeneration
    Sakuma, Ayano
    Wakuta, Makiko
    Noumi, Nanami
    Aoki, Ren
    Yoshikawa, Rina
    Higashijima, Fumiaki
    Ogata, Tadahiko
    Ota, Manami
    Kimura, Kazuhiro
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2024, 65 (07)
  • [25] Economic Evaluation of Anti-Vascular Endothelial Growth Factor Therapy for Wet Age-Related Macular Degeneration
    Brown, Melissa M.
    Brown, Gary C.
    JAMA OPHTHALMOLOGY, 2020, 138 (01) : 48 - 49
  • [26] Arteriosclerotic Changes after Intravitreal Injections of Anti-Vascular Endothelial Growth Factor Drugs in Patients with Exudative Age-Related Macular Degeneration
    Shiba, Tomoaki
    Takahashi, Mao
    Yoshida, Izumi
    Taniguchi, Hikari
    Matsumoto, Tadashi
    Hori, Yuichi
    OPHTHALMOLOGICA, 2016, 235 (04) : 225 - 232
  • [27] NON-RESPONSIVENESS AND TACHYPHYLAXIS TO ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR TREATMENT IN NAIVE PATIENTS WITH EXUDATIVE AGE-RELATED MACULAR DEGENERATION
    Zuber-Laskawiec, K.
    Kubicka-Trzaska, A.
    Karska-Basta, I
    Pociej-Marciak, W.
    Romanowska-Dixon, B.
    JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY, 2019, 70 (05): : 779 - 785
  • [28] Association of Intravitreal Anti-Vascular Endothelial Growth Factor Therapy With Risk of Stroke, Myocardial Infarction, and Death in Patients With Exudative Age-Related Macular Degeneration
    Dalvin, Lauren A.
    Starr, Matthew R.
    AbouChehade, Jackson E.
    Damento, Gena M.
    Garcia, Maria
    Shah, Saumya M.
    Hodge, David O.
    Meissner, Irene
    Bakri, Sophie J.
    Iezzi, Raymond
    JAMA OPHTHALMOLOGY, 2019, 137 (05) : 483 - 490
  • [29] Experiences of patients with age-related macular degeneration receiving anti-vascular endothelial growth factor therapy: A qualitative study The
    Burton, Amy E.
    Shaw, Rachel
    Gibson, Jonathan
    BRITISH JOURNAL OF VISUAL IMPAIRMENT, 2013, 31 (03) : 178 - 188
  • [30] Reading Speed after Anti-vascular Endothelial Growth Factor Therapy in Patients with Wet Age-related Macular Degeneration
    Moon, Tae Hwan
    Lee, Seungheon
    Kim, Jae Hyung
    Kim, Dong Yoon
    Chae, Ju Byung
    JOURNAL OF THE KOREAN OPHTHALMOLOGICAL SOCIETY, 2021, 62 (01): : 68 - 76